208 related articles for article (PubMed ID: 348295)
1. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
[TBL] [Abstract][Full Text] [Related]
2. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
Tormey DC; Waalkes TP; Ahmann D; Gehrke CW; Zumwatt RW; Snyder J; Hansen H
Cancer; 1975 Apr; 35(4):1095-100. PubMed ID: 1116102
[TBL] [Abstract][Full Text] [Related]
3. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
Tormey DC; Waalkes TP; Gehrke CW
J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
[TBL] [Abstract][Full Text] [Related]
4. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
7. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
8. Biologic markers in breast carcinoma: clinical correlations with urinary polyamines.
Tormey DC; Waalkes TP; Kuo KC; Gehrke CW
Cancer; 1980 Aug; 46(4):741-7. PubMed ID: 7397636
[TBL] [Abstract][Full Text] [Related]
9. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer.
Löser C; Fölsch UR; Paprotny C; Creutzfeldt W
Cancer; 1990 Feb; 65(4):958-66. PubMed ID: 2297664
[TBL] [Abstract][Full Text] [Related]
10. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
Heldman DA; Grever MR; Miser JS; Trewyn RW
J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
[TBL] [Abstract][Full Text] [Related]
11. [Urinary polyamines before and after treatment of malignant tumors].
Martinović S; Filipović D
Srp Arh Celok Lek; 1989; 117(7-8):465-71. PubMed ID: 2595471
[TBL] [Abstract][Full Text] [Related]
12. Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung.
Woo KB; Waalkes TP; Abeloff MD; Lenhard RE; Gehrke CW; Kuo KC
Cancer; 1983 Nov; 52(9):1684-90. PubMed ID: 6311401
[TBL] [Abstract][Full Text] [Related]
13. Polyamines as markers of response and disease activity in cancer chemotherapy.
Durie BG; Salmon SE; Russell DH
Cancer Res; 1977 Jan; 37(1):214-21. PubMed ID: 830407
[TBL] [Abstract][Full Text] [Related]
14. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
15. Differential excretion of modified nucleosides in adult acute leukemia.
Heldman DA; Grever MR; Trewyn RW
Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of polyamines by patients with advanced malignancy.
Waalkes TP; Gehrke CW; Tormey DC; Zumwalt RW; Hueser JN; Kuo KC; Lakings DB; Ahmann DL; Moertel CG
Cancer Chemother Rep; 1975; 59(6):1103-16. PubMed ID: 1222394
[TBL] [Abstract][Full Text] [Related]
17. Polyamine excretion in the urine of cancer patients.
Dreyfuss F; Chayen R; Dreyfuss G; Dvir R; Ratan J
Isr J Med Sci; 1975 Aug; 11(8):785-95. PubMed ID: 1165175
[TBL] [Abstract][Full Text] [Related]
18. Urinary putrescine, spermidine, and spermine in human blood and solid cancers and in an experimental gastric tumor of rats.
Fujita K; Nagatsu T; Maruta K; Ito M; Senba H
Cancer Res; 1976 Apr; 36(4):1320-4. PubMed ID: 1260758
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
Waalkes TP; Dinsmore SR; Mrochek JE
J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
[No Abstract] [Full Text] [Related]
20. Simplified micro-method for the quantitative analysis of putrescine, spermidine and spermine in urine.
Heby O; Andersson G
J Chromatogr; 1978 Jan; 145(1):73-80. PubMed ID: 621249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
